What is the purpose of this 8-K filing?

This 8-K filing primarily announces the details surrounding MetLife Inc.'s issuance of its 4.75% Non-Cumulative Preferred Stock, Series F, and the associated depositary shares. It outlines the terms of this new preferred stock, the agreements related to its public offering, and the implications for MetLife's capital structure and future dividend payments.

How does the new Preferred Stock impact MetLife's common stock?

The issuance of the Preferred Stock introduces a key restriction: if MetLife fails to declare and pay (or set aside) dividends on the Preferred Stock for a dividend period, the company's ability to declare or pay dividends on, or repurchase, its common stock (and any securities ranking junior to or on parity with the Preferred Stock) will be restricted. This is a critical point for common stockholders to monitor.

What are depositary shares?

Depositary shares are securities that represent an ownership interest in a share of preferred stock held by a depositary bank. In this case, each depositary share represents a 1/1,000th interest in a share of MetLife's 4.75% Non-Cumulative Preferred Stock, Series F, making it easier for investors to trade smaller denominations of preferred stock.

What is the significance of the 4.75% dividend rate?

The 4.75% dividend rate specifies the annual dividend yield that holders of the Preferred Stock are entitled to receive, assuming dividends are declared. It is important to note that this dividend is 'non-cumulative,' meaning that if a dividend payment is missed, MetLife is not obligated to make up that missed payment in the future.

METLIFE INC 8-K: Shareholder Matters & Corporate Changes

Summary

MetLife Inc. has filed an 8-K report detailing the issuance of its 4.75% Non-Cumulative Preferred Stock, Series F, and associated depositary shares. This filing is significant as it introduces new terms for preferred stock that impose restrictions on MetLife's ability to pay dividends on or repurchase its common stock and other junior or parity securities if preferred dividends are not met. This move is part of a broader capital markets transaction to raise funds, with the company entering into underwriting and pricing agreements for the sale of depositary shares representing interests in this preferred stock. Investors should note that the effective date of the Certificate of Designations for this preferred stock was January 8, 2020, with the issuance expected on January 15, 2020. The terms of this preferred stock, including the dividend payment requirements and the subsequent restrictions on common stock actions, are crucial for understanding potential impacts on shareholder returns and the company's financial flexibility. The offering is registered under MetLife's existing Form S-3 registration statement, indicating a public offering of these new securities.

Key Highlights

1MetLife Inc. is issuing 4.75% Non-Cumulative Preferred Stock, Series F.
2The issuance of this preferred stock imposes restrictions on MetLife's ability to pay dividends on or repurchase common stock if preferred dividends are not paid.
3The company entered into Underwriting and Pricing Agreements on January 7, 2020, for the sale of 40,000,000 depositary shares, each representing a 1/1,000th interest in a share of the Preferred Stock.
4The Certificate of Designations for the Preferred Stock was filed on January 8, 2020, and became effective on that date.
5The expected issuance date for the Preferred Stock is January 15, 2020.
6The offering is registered under MetLife's Form S-3 registration statement (File No. 333-234761).

METLIFE INC 8-K Report, Rights Modification (Jan 9, 2020)

Summary

Key Highlights

Frequently Asked Questions